Toy company challenges Trump's tariffs before the Supreme Court in long shot bid for quick decision
WASHINGTON — An Illinois toy company challenged President Donald Trump's tariffs in front of the Supreme Court on Tuesday in a long shot bid to press the justices to quickly decide whether they are legal.
Learning Resources Inc. filed an appeal asking the Supreme Court to take up the case soon rather than let it continue to play out in lower courts. The company argues the Republican president illegally imposed tariffs under an emergency powers law rather than getting approval from Congress.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Washington Post
32 minutes ago
- Washington Post
First face-to-face between the leaders of US and Mexico will have to wait
MEXICO CITY — For Mexican President Claudia Sheinbaum, the bilateral meetings scheduled on the sidelines of the Group of Seven summit in Canada Tuesday were even more important than the summit itself and her first face-to-face dialogue with U.S. President Donald Trump was to headline her trip. But Trump's decision to return to Washington early left a gaping hole in Mexico's schedule and delayed a much anticipated encounter. Sheinbaum had been expected to continue making the case for Mexican strides in security and immigration, while negotiating to lift steel and aluminum tariffs and lobbying to kill a proposed tax on money Mexicans in the U.S. send home .
Yahoo
32 minutes ago
- Yahoo
KPMG Women's PGA raises purse to $12 million, adds Featured Groups to broadcast lineup
The 11th edition of the KPMG Women's PGA will feature more bells and whistles than ever before, not to mention more money. On Tuesday, tournament officials announced a purse increase to $12 million, matching the U.S. Women's Open for the highest prize fund on tour. For perspective, just four years ago the purse was $4.5 million. The 156-player field, which features the top 100 players in the Race to CME Globe rankings, will take on the Fields Ranch East course June 19-22 at PGA Frisco. It marks the second major championship for the young course, which opened in May 2023. Steve Stricker won the PGA Senior in a playoff against Padraig Harrington two years ago. Advertisement In addition to the strong purse and field, the championship's broadcast coverage will include nearly 100 hours of live, streaming and ancillary coverage across NBC, Golf Channel and Peacock. And, for the first time, Featured Groups presented by KPMG and T-Mobile for Business, will be available on Peacock. LPGA Hall of Famer Judy Rankin and Grant Boone will be in the booth for Featured Groups coverage. For several years ago, KPMG has been the driving force behind the LPGA's enhanced stats offerings with the season-long KPMG Performance Insights. Once again, the championship will offer KPMG Champcast, which uses the same ShotLink Pro technology from the PGA Tour along with new AI-enhanced features. This year, players will receive a KPMG Performance Insights Daily Recap that includes hole-by-hole AI-powered analysis and AI-generated scoring targets of where the cut might fall and the winning score. 'KPMG's commitment to excellence extends to women's golf, and through our collaboration with the PGA of America and LPGA Tour, the KPMG Women's PGA Championship is the best event on the LPGA Tour,' Paul Knopp, KPMG U.S. Chair and CEO said in a statement. Advertisement 'The high purse, top courses, comprehensive broadcast coverage, and technology are all ways we are setting the standard. Technology is changing business and sports and, similar to the AI enablement we deliver for our clients, we're equipping LPGA players with new AI capabilities through KPMG Performance Insights, enabling them to take their game to new heights.' This article originally appeared on Golfweek: KPMG Women's PGA raises purse to $12 million, adds Featured Groups
Yahoo
32 minutes ago
- Yahoo
Vistagen to Report Fiscal Year 2025 Financial Results and Host Corporate Update Conference Call on June 17, 2025
SOUTH SAN FRANCISCO, Calif., June 12, 2025--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, today announced it will host a conference call and webcast on Tuesday, June 17, 2025, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to report results for its fiscal year 2025 ended March 31, 2025, and provide a corporate update. The conference call is being webcast live, and a link can be found under "Events" in the Investors section of the Company's website. Participants may register to join the live call by following the link here to receive the dial-in numbers and unique PIN to access the call. Those who plan on participating are advised to join 15 minutes prior to the start time. A webcast replay of the call will be available on Vistagen's website about 24 hours after the end of the live conference call and will be accessible for at least 30 days. About Vistagen Headquartered in South San Francisco, CA, Vistagen (Nasdaq: VTGN) is a late clinical-stage biopharmaceutical company leveraging a deep understanding of nose-to-brain neurocircuitry to develop and commercialize a broad and diverse pipeline of clinical-stage product candidates from a new class of intranasal product candidates called pherines. Pherines specifically and selectively bind as agonists to peripheral receptors on human nasal chemosensory neurons and are designed to rapidly activate olfactory bulb-to-brain neurocircuits believed to regulate brain areas involved in behavior and autonomic nervous system activity. They are designed to achieve therapeutic benefits without requiring absorption into the blood or uptake into the brain, giving them the potential to be a safer alternative to other pharmacological options if successfully developed and approved. Vistagen's neuroscience pipeline also includes an oral prodrug with potential to treat certain neurological conditions involving the NMDA receptor. Vistagen is passionate about developing transformative treatment options to improve the lives of individuals underserved by the current standard of care for multiple highly prevalent indications, including social anxiety disorder, major depressive disorder, and multiple women's health conditions, including vasomotor symptoms (hot flashes) associated with menopause. Connect at View source version on Contacts Investor Inquiries: Mark A. McPartlandmarkmcp@ Media Inquiries: Michelle P. Wellingtonmwellington@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
